Global /United States /Healthcare /Medical Devices /CBSC
chevron_leftBack
Cardiac Biotech Solutions Inc. logo

Cardiac Biotech Solutions Inc.

CBSC
OTCMKTS: CBSC Delayed
0.0300USD -25%
As of 14 June 2026, Cardiac Biotech Solutions Inc. has a market cap of $4.96M USD, ranking #44518 globally and #5670 in the United States. It ranks #3939 in the Healthcare sector, and #833 in the Medical Devices industry.
Global Rank
44518
Country Rank
5670
Sector Rank
3939
Industry Rank
833
Key Stats
Market Cap
$4.96MUSD
Revenue (TTM)
$50.37KUSD
Net Income (TTM)
-$640.55KUSD
PS Ratio
98.5
PB Ratio
-3.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Charles Martin open_in_new
Employees
5
Website
cardiacbiotech.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-25% -23% -0.3% 0% -25% -24%

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
CBSC
Cardiac Biotech Solutions Inc
ISIN: US12506E1038
Shares Out.:
165.439M1
TV:
SA:
YF:
GF:
BA:
MS:
0.0300 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Cardiac Biotech Solutions Inc.

Cardiac Biotech Solutions Inc., through its subsidiaries, provides ambulatory non-invasive cardiac monitoring products and services in the United States and internationally. It offers My-Cardia devices, interactive cloud-based acquisition software, and smartphone apps for patients at risk of abnormal heart rhythms. The company was formerly known as CB Scientific, Inc. and changed its name to Cardiac Biotech Solutions Inc. in May 2025. The company is based in Las Vegas, Nevada.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
3M%
25.8
$160.73B
3M%
56.7
$159.07B
3M%
25.6
DHR
$126.55B
3M%
34.7
SYK
$120.69B
2M%
38.3
$84.93B
2M%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
2M%
22.2
$97.46B
84.32B EUR
2M%
36.7
7741
$61.41B
9.83T JPY
1M%
40.0
$45.47B
39.34B EUR
916K%
18.7
ALC
$36.38B
28.99B CHF
733K%
37.9
$30.06B
203.66B CNY
605K%
26.0
chevron_leftBack